SynAct Pharma
Sweden - Lund
PharmaceuticalFocus: Small Molecule Targeting Inflammation without Immunosuppression
SynAct Pharma is a life sciences company focused on Small Molecule Targeting Inflammation without Immunosuppression.
Immunology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
AP1189, 40 mg
Rheumatoid Arthritis (RA)Clinical Trials (1)
NCT06671054A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis
Phase 2Phase 2
Clinical Trials (1)
NCT04456816A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria
Phase 2AP1189, 60 mg
Rheumatoid ArthritisClinical Trials (1)
NCT05604885A Dose-range Study of the Safety and Efficacy of Treatment in Adult Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
Phase 250 mg AP1189
Rheumatoid ArthritisClinical Trials (1)
NCT04004429A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint Disease
Phase 2100 mg AP1189
Rheumatoid ArthritisClinical Trials (1)
NCT05516979A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 5 clinical trials
Top TAs: Immunology, Nephrology
Publications: 2 in PubMed